# Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.

> **NCT02283827** · PHASE1 · COMPLETED · sponsor: **Bial - Portela C S.A.** · enrollment: 32 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** BIA 2-093
- **DRUG:** Phenytoin

## Key facts

- **NCT ID:** NCT02283827
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02283827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02283827, "Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT02283827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*